로딩 중…
지수 로딩 중…
DONGWHA PHARM.CO.,LTD
000020· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,080-2.12%
2026-06-19
Price Chart
DONGWHA PHARM.CO.,LTD-25.73%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 141.89B KRW |
| Revenue | 501.33B KRW |
| Net Income | 454.0M KRW |
| Total Assets | 647.92B KRW |
| Net Assets | 409.65B KRW |
| Employees | 824 |
| Value | |
| P/E | 312.52x |
| P/B | 0.35x |
| PEG | 0.01x |
| P/S | 0.28x |
| EV/EBITDA | 47.73x |
| FCF Yield | -26.41% |
| Profitability | |
| ROE | 0.11% |
| ROA | 0.07% |
| Op. Margin | 0.99% |
| Revenue Growth | 3.93% |
| Earnings Growth | 28017.05% |
| Financial Health | |
| Debt Ratio | 158.17% |
| Total Debt | 105.47B KRW |
| FCF | -37.48B KRW |
| Cash | 10.50B KRW |
| Current Ratio | 1.16x |
| Net Debt/EBITDA | 19.14x |
| Dividend | |
| Div. Yield | 1.25% |
| Div. Growth | -63.89% |
| Performance | |
| 1Y Return | -25.73% |
| 1M Return | -14.48% |
| From 52W High | -28.85% |
| 1Y MDD | -28.05% |
| Trading | |
| Volume | 133,057 shares |
| Foreign Own. | 2.73% |
| Per Share | |
| EPS | 668 KRW |
| BPS | 13,998 KRW |
Company Info
Established in 1897 and listed on the Stock Market in 1976, this pharmaceutical company acquired medical device manufacturer Medyssey in 2020 and Vietnamese pharmaceutical distribution chain TS Care in 2023. It specializes in manufacturing and selling pharmaceuticals, active pharmaceutical ingredients, quasi-drugs, and medical devices, also producing health functional foods. The company targets sustainable growth by addressing an aging society, improving economic standards, and developing biotech new drugs for intractable diseases. Dong Wha Pharmaceutical is headquartered in Jung-gu, Seoul Metropolitan City.